The N-acetyltransferase 10 inhibitor [11C]remodelin: synthesis and preliminary positron emission tomography study in mice

Abstract Background 4-(4-Cyanophenyl)-2-(2-cyclopentylidenehydrazinyl)thiazole (remodelin) is a potent N-acetyltransferase 10 (NAT10) inhibitor. This compound inhibits tumors and weakens tumor resistance to antitumor drugs. Moreover, remodelin has been found to enhance healthspan in an animal model...

Full description

Saved in:
Bibliographic Details
Main Authors: Rui Luo, Yiding Zhang, Katsushi Kumata, Lin Xie, Yusuke Kurihara, Masanao Ogawa, Tomomi Kokufuta, Nobuki Nengaki, Feng Wang, Ming-Rong R. Zhang
Format: Article
Language:English
Published: SpringerOpen 2025-01-01
Series:EJNMMI Radiopharmacy and Chemistry
Subjects:
Online Access:https://doi.org/10.1186/s41181-025-00330-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571149428457472
author Rui Luo
Yiding Zhang
Katsushi Kumata
Lin Xie
Yusuke Kurihara
Masanao Ogawa
Tomomi Kokufuta
Nobuki Nengaki
Feng Wang
Ming-Rong R. Zhang
author_facet Rui Luo
Yiding Zhang
Katsushi Kumata
Lin Xie
Yusuke Kurihara
Masanao Ogawa
Tomomi Kokufuta
Nobuki Nengaki
Feng Wang
Ming-Rong R. Zhang
author_sort Rui Luo
collection DOAJ
description Abstract Background 4-(4-Cyanophenyl)-2-(2-cyclopentylidenehydrazinyl)thiazole (remodelin) is a potent N-acetyltransferase 10 (NAT10) inhibitor. This compound inhibits tumors and weakens tumor resistance to antitumor drugs. Moreover, remodelin has been found to enhance healthspan in an animal model of the human accelerated ageing syndrome. In this study, we synthesized C-11-labelled remodelin ([11C]remodelin) for the first time as a positron emission tomography (PET) probe and assessed its biodistribution in mice using PET. Results [11C]Remodelin was synthesized by the reaction of a boron ester precursor (1) with hydrogen [11C]cyanide, which was prepared from the cyclotron-produced [11C]carbon dioxide via [11C]methane. The decay-corrected radiochemical yield of [11C]remodelin was 6.2 ± 2.3% (n = 20, based on [11C]carbon dioxide) with a synthesis time of 45 min and radiochemical purity of > 90%. A PET study with [11C]remodelin showed high uptake of radioactivity in the heart, liver, and small intestine of mice. The metabolite analysis indicated moderate metabolism of [11C]remodelin in the heart. Conclusions In the present study, we successfully synthesized [11C]remodelin and assessed its biodistribution of radioactivity in the mouse organs and tissues with PET. We are planning to prepare tumor and inflammatory models in which overexpression of NAT10 is possibly induced and conduct PET imaging for these animal models with [11C]remodelin to elucidate the relationship between NAT10 and diseases.
format Article
id doaj-art-227b61fbf3254939ba54e6c7f14f0e65
institution Kabale University
issn 2365-421X
language English
publishDate 2025-01-01
publisher SpringerOpen
record_format Article
series EJNMMI Radiopharmacy and Chemistry
spelling doaj-art-227b61fbf3254939ba54e6c7f14f0e652025-02-02T12:48:32ZengSpringerOpenEJNMMI Radiopharmacy and Chemistry2365-421X2025-01-0110111410.1186/s41181-025-00330-1The N-acetyltransferase 10 inhibitor [11C]remodelin: synthesis and preliminary positron emission tomography study in miceRui Luo0Yiding Zhang1Katsushi Kumata2Lin Xie3Yusuke Kurihara4Masanao Ogawa5Tomomi Kokufuta6Nobuki Nengaki7Feng Wang8Ming-Rong R. Zhang9Department of Advanced Nuclear Medicine Sciences, Institute of Quantum Medical Science, National Institutes for Quantum Science and TechnologyDepartment of Advanced Nuclear Medicine Sciences, Institute of Quantum Medical Science, National Institutes for Quantum Science and TechnologyDepartment of Advanced Nuclear Medicine Sciences, Institute of Quantum Medical Science, National Institutes for Quantum Science and TechnologyDepartment of Advanced Nuclear Medicine Sciences, Institute of Quantum Medical Science, National Institutes for Quantum Science and TechnologyDepartment of Advanced Nuclear Medicine Sciences, Institute of Quantum Medical Science, National Institutes for Quantum Science and TechnologyDepartment of Advanced Nuclear Medicine Sciences, Institute of Quantum Medical Science, National Institutes for Quantum Science and TechnologyDepartment of Advanced Nuclear Medicine Sciences, Institute of Quantum Medical Science, National Institutes for Quantum Science and TechnologyDepartment of Advanced Nuclear Medicine Sciences, Institute of Quantum Medical Science, National Institutes for Quantum Science and TechnologyDepartment of Advanced Nuclear Medicine Sciences, Institute of Quantum Medical Science, National Institutes for Quantum Science and TechnologyDepartment of Advanced Nuclear Medicine Sciences, Institute of Quantum Medical Science, National Institutes for Quantum Science and TechnologyAbstract Background 4-(4-Cyanophenyl)-2-(2-cyclopentylidenehydrazinyl)thiazole (remodelin) is a potent N-acetyltransferase 10 (NAT10) inhibitor. This compound inhibits tumors and weakens tumor resistance to antitumor drugs. Moreover, remodelin has been found to enhance healthspan in an animal model of the human accelerated ageing syndrome. In this study, we synthesized C-11-labelled remodelin ([11C]remodelin) for the first time as a positron emission tomography (PET) probe and assessed its biodistribution in mice using PET. Results [11C]Remodelin was synthesized by the reaction of a boron ester precursor (1) with hydrogen [11C]cyanide, which was prepared from the cyclotron-produced [11C]carbon dioxide via [11C]methane. The decay-corrected radiochemical yield of [11C]remodelin was 6.2 ± 2.3% (n = 20, based on [11C]carbon dioxide) with a synthesis time of 45 min and radiochemical purity of > 90%. A PET study with [11C]remodelin showed high uptake of radioactivity in the heart, liver, and small intestine of mice. The metabolite analysis indicated moderate metabolism of [11C]remodelin in the heart. Conclusions In the present study, we successfully synthesized [11C]remodelin and assessed its biodistribution of radioactivity in the mouse organs and tissues with PET. We are planning to prepare tumor and inflammatory models in which overexpression of NAT10 is possibly induced and conduct PET imaging for these animal models with [11C]remodelin to elucidate the relationship between NAT10 and diseases.https://doi.org/10.1186/s41181-025-00330-1[11C]remodelin, RadiosynthesisHydrogen [11C]cyanidePositron emission tomography
spellingShingle Rui Luo
Yiding Zhang
Katsushi Kumata
Lin Xie
Yusuke Kurihara
Masanao Ogawa
Tomomi Kokufuta
Nobuki Nengaki
Feng Wang
Ming-Rong R. Zhang
The N-acetyltransferase 10 inhibitor [11C]remodelin: synthesis and preliminary positron emission tomography study in mice
EJNMMI Radiopharmacy and Chemistry
[11C]remodelin, Radiosynthesis
Hydrogen [11C]cyanide
Positron emission tomography
title The N-acetyltransferase 10 inhibitor [11C]remodelin: synthesis and preliminary positron emission tomography study in mice
title_full The N-acetyltransferase 10 inhibitor [11C]remodelin: synthesis and preliminary positron emission tomography study in mice
title_fullStr The N-acetyltransferase 10 inhibitor [11C]remodelin: synthesis and preliminary positron emission tomography study in mice
title_full_unstemmed The N-acetyltransferase 10 inhibitor [11C]remodelin: synthesis and preliminary positron emission tomography study in mice
title_short The N-acetyltransferase 10 inhibitor [11C]remodelin: synthesis and preliminary positron emission tomography study in mice
title_sort n acetyltransferase 10 inhibitor 11c remodelin synthesis and preliminary positron emission tomography study in mice
topic [11C]remodelin, Radiosynthesis
Hydrogen [11C]cyanide
Positron emission tomography
url https://doi.org/10.1186/s41181-025-00330-1
work_keys_str_mv AT ruiluo thenacetyltransferase10inhibitor11cremodelinsynthesisandpreliminarypositronemissiontomographystudyinmice
AT yidingzhang thenacetyltransferase10inhibitor11cremodelinsynthesisandpreliminarypositronemissiontomographystudyinmice
AT katsushikumata thenacetyltransferase10inhibitor11cremodelinsynthesisandpreliminarypositronemissiontomographystudyinmice
AT linxie thenacetyltransferase10inhibitor11cremodelinsynthesisandpreliminarypositronemissiontomographystudyinmice
AT yusukekurihara thenacetyltransferase10inhibitor11cremodelinsynthesisandpreliminarypositronemissiontomographystudyinmice
AT masanaoogawa thenacetyltransferase10inhibitor11cremodelinsynthesisandpreliminarypositronemissiontomographystudyinmice
AT tomomikokufuta thenacetyltransferase10inhibitor11cremodelinsynthesisandpreliminarypositronemissiontomographystudyinmice
AT nobukinengaki thenacetyltransferase10inhibitor11cremodelinsynthesisandpreliminarypositronemissiontomographystudyinmice
AT fengwang thenacetyltransferase10inhibitor11cremodelinsynthesisandpreliminarypositronemissiontomographystudyinmice
AT mingrongrzhang thenacetyltransferase10inhibitor11cremodelinsynthesisandpreliminarypositronemissiontomographystudyinmice
AT ruiluo nacetyltransferase10inhibitor11cremodelinsynthesisandpreliminarypositronemissiontomographystudyinmice
AT yidingzhang nacetyltransferase10inhibitor11cremodelinsynthesisandpreliminarypositronemissiontomographystudyinmice
AT katsushikumata nacetyltransferase10inhibitor11cremodelinsynthesisandpreliminarypositronemissiontomographystudyinmice
AT linxie nacetyltransferase10inhibitor11cremodelinsynthesisandpreliminarypositronemissiontomographystudyinmice
AT yusukekurihara nacetyltransferase10inhibitor11cremodelinsynthesisandpreliminarypositronemissiontomographystudyinmice
AT masanaoogawa nacetyltransferase10inhibitor11cremodelinsynthesisandpreliminarypositronemissiontomographystudyinmice
AT tomomikokufuta nacetyltransferase10inhibitor11cremodelinsynthesisandpreliminarypositronemissiontomographystudyinmice
AT nobukinengaki nacetyltransferase10inhibitor11cremodelinsynthesisandpreliminarypositronemissiontomographystudyinmice
AT fengwang nacetyltransferase10inhibitor11cremodelinsynthesisandpreliminarypositronemissiontomographystudyinmice
AT mingrongrzhang nacetyltransferase10inhibitor11cremodelinsynthesisandpreliminarypositronemissiontomographystudyinmice